Physician

Michael Brian Zaycosky, D.O.

According to 2025 Medicare claims, Michael Zaycosky, D.O. (NPI: 1174789507) practices dermatology in the Erie, PA market, with the plurality of this provider's patient population coming from Erie, PA. This provider's primary affiliated billing organization is LIVE OAK DERMATOLOGY PC (NPI: 1609654466; TIN: 921640634) and primary practice location at 16415-2027.

Zaycosky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 469 traditional Medicare patients, billed 1,807 HCPCS/CPT codes, and received $143,533 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 789 prescription claims across 399 beneficiaries totaling $128,612 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 72 records totaling $1,301. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$152K$304K2018 Medicare payment: $4,283 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $303,658 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $206,521 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $233,051 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $176,758 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $143,533 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181437$4,283
20199814,801$303,658
20206352,882$206,521
20216673,153$233,051
20225642,817$176,758
2023N/RN/RN/R
20244691,807$143,533

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$681K$1.4M2016 Drug cost: $31,162 (USD; Tot_Drug_Cst)2017 Drug cost: $22,717 (USD; Tot_Drug_Cst)2018 Drug cost: $34,792 (USD; Tot_Drug_Cst)2019 Drug cost: $358,186 (USD; Tot_Drug_Cst)2020 Drug cost: $316,456 (USD; Tot_Drug_Cst)2021 Drug cost: $505,192 (USD; Tot_Drug_Cst)2022 Drug cost: $1,362,354 (USD; Tot_Drug_Cst)2023 Drug cost: $235,831 (USD; Tot_Drug_Cst)2024 Drug cost: $128,612 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161326$31,162
20172236$22,717
201887136$34,792
2019382789$358,186
2020372791$316,456
2021443982$505,192
2022415971$1,362,354
20233567$235,831
2024399789$128,612

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more377377$75
11102Biopsy of related skin growth, first growth117132$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more138191$68
17000Destruction of precancer skin growth, 1 growth142164$39
17003Destruction of precancer skin growth, 2-14 growths97442$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab20546$75,125
Clobetasol PropionateClobetasol Propionate1143,192$4,369
Triamcinolone AcetonideTriamcinolone Acetonide2688,344$2,316
TacrolimusTacrolimus21624$1,857
Betamethasone DipropionateBetamethasone Dipropionate32910$1,595

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.72$1,301GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Brian Zaycosky, D.O.?

Tedicare shows public-source Medicare data for Michael Brian Zaycosky, D.O. (NPI 1174789507), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Brian Zaycosky, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Brian Zaycosky, D.O.?

Michael Brian Zaycosky, D.O. is linked to LIVE OAK DERMATOLOGY PC (billing NPI 1609654466) in the available physician profile data.

Does Michael Brian Zaycosky, D.O. have Open Payments data?

Michael Brian Zaycosky, D.O. has 72 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.